AIM ImmunoTech Reports Positive Mid-Year Safety And Efficacy Data From Phase 2 Study Evaluating Ampligen® (Rintatolimod) In Combination With AstraZeneca’S Imfinzi® (Durvalumab) For The Treatment Of Pancreatic Cancer

TradingKey - Today's gold (XAUUSD) market logic in one sentence: safe-haven sentiment persists, but stronger interest rates and the US dollar are weighing on gold prices.

Gold prices have fallen below the $5,000 mark and currently remain under pressure, with the potential for a further decline of approximately 7%.

Gold recently hit all-time highs above $5,500 - $5,627 in January 2026 before pulling back to current levels. And that brings us to this week - arguably the most closely watched Fed meeting of the year.

TradingKey - During the 2026 GTC Conference, NVIDIA (NVDA) CEO Jensen Huang’s keynote speech and a series of partnerships and technical launches sent ripples through the global technology supply chain. From computing hardware to application scenarios, multiple sectors are seeing clear investment opp

Crude oil volatility has been relatively subdued this week, but a research report from JPMorgan’s (JPM) Head of Commodities Strategy Natasha Kaneva and her team noted that the relative stability of Brent and WTI does not signify ample global supply. According to reports, prices for Oman and Dubai crude futures have both exceeded $150. JPMorgan pointed out that the current price stability is an illusion, created by a combination of regional inventory buffers, benchmark pricing structure biases, and policy interventions.